Endocrinology, Vol 137, 831-838, Copyright © 1996 by Endocrine Society

ARTICLES

Effects of the mutations (Trp8 --> Arg and Ile15 --> Thr) in human luteinizing hormone (LH) beta-subunit on LH bioactivity in vitro and in vivo

N Suganuma, K Furui, F Kikkawa, Y Tomoda and M Furuhashi
Department of Obstetrics and Gynecology, Nagoya University School of Medicine, Nagoya, Japan.

The mutations (Trp8 --> Arg and Ile15 --> Thr) in the human LHbeta - subunit caused by nucleotide point mutations in the LHbeta gene were reported in women with immunologically anomalous LH and menstrual disorders. To estimate the effects of the mutations on LH bioactivity in vitro and in vivo, we constructed a LHbeta gene containing this nucleotide mutation in each site or in both sites by site- directed mutagenesis and analyzed the bioactivities of the mutant LH expressed in Chinese hamster ovary cells. Although no alterations were noted in the receptor-binding activity of LH due to the mutations, the LHs containing the mutations at Trp8 --> Arg and at both sites in the beta- subunit showed a higher biopotency of progesterone production in vitro. The clearance rate from the circulation was faster in vivo in all mutant LHs, which were induced primarily by the mutation at Trp8 --> Arg. However, the mutations did not affect the ability of LH to induce ovulation in vivo. These results indicate that LH consisting of the mutant beta-subunit exhibits hyperbioactivity on steroidogenesis and has a short turnover rate. This may affect the endocrine pathway among women with the mutant LH and lead to menstrual disorders.

This article has been cited by other articles:

				T. Lamminen, M. Jiang, P. R. Manna, P. Pakarinen, H. Simonsen, R. J. Herrera, and I. Huhtaniemi Functional study of a recombinant form of human LH{beta}-subunit variant carrying the Gly102Ser mutation found in Asian populations Mol. Hum. Reprod., October 1, 2002; 8(10): 887 - 892. [Abstract] [Full Text] [PDF]

				R. Gazvani, P. Pakarinen, P. Fowler, S. Logan, and I. Huhtaniemi Lack of association of the common immunologically anomalous LH with endometriosis Hum. Reprod., June 1, 2002; 17(6): 1532 - 1534. [Abstract] [Full Text] [PDF]

				M. Jiang, T. Lamminen, P. Pakarinen, J. Hellman, P. Manna, R. J. Herrera, and I. Huhtaniemi A novel Ala-3Thr mutation in the signal peptide of human luteinizing hormone {beta}-subunit: potentiation of the inositol phosphate signalling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone Mol. Hum. Reprod., March 1, 2002; 8(3): 201 - 212. [Abstract] [Full Text] [PDF]

				P. R. Manna, L. Joshi, V. N. Reinhold, M. L. Aubert, N. Suganuma, K. Pettersson, and I. T. Huhtaniemi Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone Hum. Mol. Genet., February 1, 2002; 11(3): 301 - 315. [Abstract] [Full Text] [PDF]

				A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte, K. S. Pettersson, and I. T. Huhtaniemi Luteinizing Hormone, Its {beta}-Subunit Variant, and Epithelial Ovarian Cancer: The Gonadotropin Hypothesis Revisited Am. J. Epidemiol., July 1, 2001; 154(1): 43 - 49. [Abstract] [Full Text] [PDF]

				C.H. Nilsson, M. Kaleva, H. Virtanen, A.M. Haavisto, K. Pettersson, and I.T. Huhtaniemi Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LH{beta} variant allele Hum. Reprod., February 1, 2001; 16(2): 230 - 235. [Abstract] [Full Text] [PDF]

				A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text]

				D.W. Cramer, K.S.I. Petterson, R.L. Barbieri, and I.T. Huhtaniemi Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone Hum. Reprod., October 1, 2000; 15(10): 2103 - 2107. [Abstract] [Full Text] [PDF]

				A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte, K. Pettersson, and I. Huhtaniemi Genetic Variant of Luteinizing Hormone and Risk of Breast Cancer in Older Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 839 - 842. [Abstract] [Full Text]

				A. W. van den Beld, I. T. Huhtaniemi, K. S. L. Pettersson, H. A. P. Pols, D. E. Grobbee, F. H. de Jong, and S. W. J. Lamberts Luteinizing Hormone and Different Genetic Variants, as Indicators of Frailty in Healthy Elderly Men J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1334 - 1339. [Abstract] [Full Text]

				I. Galeraud-Denis, P. Bouchard, M. Herlicoviez, E. Marie, and S. Carreau Inhibitory effect of plasma obtained from hypophysectomized and control women on the assay of bioactive luteinizing hormone Hum. Reprod., February 1, 1999; 14(2): 312 - 317. [Abstract] [Full Text] [PDF]

				J. Pantel, P. Robert, F. Troalen, M. Kujas, D. Bellet, and J.-M. Bidart Characterization of Human Lutropin Carboxyl- Terminus Isoforms Endocrinology, February 1, 1998; 139(2): 527 - 533. [Abstract] [Full Text] [PDF]

				M. Grossmann, B. D. Weintraub, and M. W. Szkudlinski Novel Insights into the Molecular Mechanisms of Human Thyrotropin Action: Structural, Physiological, and Therapeutic Implications for the Glycoprotein Hormone Family Endocr. Rev., August 1, 1997; 18(4): 476 - 501. [Abstract] [Full Text] [PDF]

				S.-B. Hu, L. Johnson, P. C. Roche, and H. T. Keutmann A Functional Determinant in Human Luteinizing Hormone and Chorionic Gonadotropin: Differential Effect of Mutations about {beta}-GLN-54 Endocrinology, April 1, 1997; 138(4): 1627 - 1633. [Abstract] [Full Text] [PDF]